HomeCompaniesProfile

AOA Dx

Blood Test for Early Detection of Ovarian Cancer  


Company Size

11 - 50 employees

Year Founded

2020


About AOA Dx

AOA Dx is developing the next frontier in early-stage cancer detection for women through our pioneering work in glycolipids and proprietary biomarker technology.

Founders & Key People

Oriana Papin-Zoghbi

Oriana Papin-Zoghbi

Founder, AOA Dx

Alex Fisher

Alex Fisher

Founder/COO, AOA Dx

Anna Jeter

Anna Jeter

Founder, AOA Dx

Share This Profile

More Companies

Athina AI

Prototype, Experiment & Evaluate AI Pipelines in a Spreadsheet-like UI

innkeeper

The Fastest Way to Apply AI Edits

Axflow

Build and publish web apps in minutes. No coding required.

MicroHealth

Digital hematology

Nephrogen

Curative gene therapies for kidney diseases

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2025 BEAMSTART. All Rights Reserved.